China Animal Husbandry to sell idle assets, amend charter, and call EGM

China Animal Husbandry Industry Co. Ltd. announced the proposed sale of idle assets from its Lanzhou Biological Pharmaceutical Factory branch and its wholly-owned subsidiary, Lanzhou China Animal Husbandry Pharmaceutical Machinery Technology Co. Ltd. The assets, located in Lanzhou City, include land, buildings, structures, and machinery, valued at 228,978,222 yuan as of August 27, 2025. This sale aims to optimize asset structure, reduce management costs, and improve resource allocation.

The company's board of directors, which met on October 27, 2025, approved a comprehensive revision of the company's charter to align with updated laws and regulations. Key amendments include the removal of the supervisory board and the transfer of its responsibilities to the audit committee. These changes will be presented for shareholder approval at the second extraordinary general meeting of 2025.

The extraordinary general meeting is scheduled for November 13, 2025, where shareholders will vote on the asset disposal and charter amendments. The company’s third-quarter report shows a 6.32% increase in revenue to 4,442,327,149.20 yuan and a 125.95% increase in total profit to 257,281,924.83 yuan year-to-date.